SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Vaccine Stocks Rally on Speculation of Contract Awards After Russia Lab Incident

Novavax (NVAX), Moderna (MRNA), Emergent BioSolutions (EBS) and Arcturus Therapeutics (ARCT) advanced after a death at a Russian plague research institute. Retail investors speculated about potential federal contract awards.

ARCTEBSNVAX

A Russian lab worker’s unexplained death in a plague research institute lifted vaccine and biodefense shares on Monday, with Novavax (NVAX), Moderna (MRNA), Emergent BioSolutions (EBS) and Arcturus Therapeutics (ARCT) advancing as retail investors speculated about federal contracts.

Related stories